Interestingly, cystine levels were elevated in CAPN2−/− cells, and cystine dependency was demonstrated to be elevated in patients with AML and a poor prognostic marker (Pardieu et al. 2022). This evidence concerns the gene CAPN2 and acute myeloid leukemia.